Exchange: NASDAQ·Updated 07:30 PM EST

OBX Obsidian Therapeutics Inc.

$12.00
$0.15
(1.24%)
Today
Closed $12.00
$0.00
(0.00%)
After Hours
Mkt Cap$741.29M
Vol336,498.00

About OBX

Obsidian Therapeutics Inc. engages in developing cell and gene therapies, particularly for the treatment of solid tumors and cancer. The company was founded on September 29, 2015 and is headquartered in Malvern, PA.
35

Bearish Sentiment

How do you feel about OBX?

JFais
$OBX (NP) Interesting SITC abstract coming up: OBX-115 TIL cell therapy in ICI-resistant advanced melanoma: Pooled safety and updated efficacy with minimally invasive tumor tissue procurement, low-dose lymphodepletion, and IL2-free regimen Slides compare 67% ORR in median 2 prior lines of therapy vs 31% for $IOVA Amtagvi pivotal trial (not a fair comparison though, as real-world data in 2 or fewer prior lines yielded 52% ORR) Favorable safety, no DLTs, treatment-related mortality or ICU stay Phase 1 NSCLC data 1H 27 En fin, on my DD list as well (not a zero sum game) $REPL $IMTX
13

Advertisement|Remove ads.